Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Long-Term Prophylaxis with Activated Recombinant FVII in Children with Hemophilia a and Inhibitor, Receiving Treatment with ITI Protocol

Ekaterina Shiller, MD, Victor Petrov, MD PhD, Pavel Svirin, MD, Vladimir Vdovin, MD, Igor Koltunov, MD PhD, Artem Bullikh, MD, Eugene Nikitin, MD PhD, Dmitry Kudlay, MD PhD Prof., Ekaterina Klykova, MD PhD

Blood (2016) 128 (22): 4980.

https://doi.org/10.1182/blood.V128.22.4980.4980

Published: 2016

Journal Articles

Platelet Function Prior to Ibrutinib Treatment Is More Severely Impaired in Chronic Lymphocytic Leukemia Than in Mantle Cell Lymphoma

Eugene Nikitin, MD PhD, Anastasia Ignatova, Vladimir Vorobyev, MD PhD, Alexander Poletaev, Dmitrii Polokhov, MD, Anton Fedotov, Elena A. Seregina, PhD, Alexey Pshonkin, Mikhail Panteleev, Professor, Vadim Ptushkin

Blood (2016) 128 (22): 4917.

https://doi.org/10.1182/blood.V128.22.4917.4917

Published: 2016

Journal Articles

Safety and Efficiency of New Nonacog Alfa Drug in the Treatment of Bleeding Episodes in Patients with Severe and Moderate Hemophilia B

Igor Davydkin, Prof., Tatiana Andreeva, MD PhD, Vladimir Yu. Zorenko, MD PhD Prof., Valeria Konstantinova, MD PhD, Olga Zalepukhina, MD, Nina Klimova, MD, Georgy Mishin, MD, Igor Kurtov, MD PhD, Maria Shamina, MD PhD, Elena Fatenkova, MD, Olga Gusyakova, MD PhD, Alexandr Shuster, Academician, PhD, Dmitry Kudlay, MD PhD Prof., Sergey Lukyanov, MD PhD, Anton Borozinets, MD PhD, Eugene Nikitin, MD PhD, Ekaterina Klykova, MD PhD

Blood (2015) 126 (23): 4690.

https://doi.org/10.1182/blood.V126.23.4690.4690

Published: 2015

Journal Articles

The Pharmacokinetic Properties, Safety and Tolerability of a New Nonacog Alfa (Innonafactor) in Patients with Hemophilia B

Vladimir Yu. Zorenko, MD PhD Prof., Georgy Mishin, MD, Tatiana Severova, MD, Alexandr Shuster, Academician, PhD, Dmitry Kudlay, MD PhD Prof., Sergey Lukyanov, MD PhD, Anton Borozinets, MD PhD, Eugene Nikitin, MD PhD, Ekaterina Klykova, MD PhD

Blood (2015) 126 (23): 4691.

https://doi.org/10.1182/blood.V126.23.4691.4691

Published: 2015

Journal Articles

Safety and Efficacy of New Moroctocog Alfa Drug (Octofactor) in Prophylactic Treatment in Adolescent Patients with Severe and Moderate Hemophilia a

Ekaterina Shiller, MD, Vladimir Vdovin, MD, Victor Petrov, MD PhD, Pavel Svirin, MD, Tatiana Andreeva, MD PhD, Inna Lavrichenko, MD, Artem Bullikh, MD, Igor Koltunov, MD PhD, Igor Davydkin, Prof., Igor Kurtov, MD PhD, Alexandr Shuster, Academician, PhD, Dmitry Kudlay, MD PhD Prof., Sergey Lukyanov, MD PhD, Anton Borozinets, MD PhD, Eugene Nikitin, MD PhD, Ekaterina Klykova, MD PhD

Blood (2015) 126 (23): 4703.

https://doi.org/10.1182/blood.V126.23.4703.4703

Published: 2015

Journal Articles

Safety and Efficacy of New Nonacog Alfa Drug (Innonafactor) in Prophylactic Treatment in Patients with Severe and Moderate Hemophilia B

Tatiana Andreeva, MD PhD, Vladimir Yu. Zorenko, MD PhD Prof., Igor Davydkin, Prof., Valeria Konstantinova, MD PhD, Olga Zalepukhina, MD, Nina Klimova, MD, Georgy Mishin, MD, Igor Kurtov, MD PhD, Maria Shamina, MD PhD, Elena Fatenkova, MD, Olga Gusyakova, MD PhD, Alexandr Shuster, Academician, PhD, Dmitry Kudlay, MD PhD Prof., Sergey Lukyanov, MD PhD, Anton Borozinets, MD PhD, Eugene Nikitin, MD PhD, Ekaterina Klykova, MD PhD

Blood (2015) 126 (23): 3532.

https://doi.org/10.1182/blood.V126.23.3532.3532

Published: 2015

Journal Articles

Low Frequency Of IGHV4-39/IGHD6-13/IGHJ5 Rearrangement With Stereotyped HCDR3 (subset #8) In Russian and Ukrainian Chronic Lymphocytic Leukemia Patients

Bella Biderman, Nadiia Bilous, Nataliya Severina, Andrey Sudarikov, Eugene Nikitin, Iryna Kryachok, Iryna Abramenko, Anatoliy Chumak

Blood (2013) 122 (21): 5276.

https://doi.org/10.1182/blood.V122.21.5276.5276

Published: 2013

Journal Articles

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

Blood (2013) 122 (15): 2673–2682.

https://doi.org/10.1182/blood-2013-03-489518

Published: 2013

Includes: Supplemental data

Journal Articles

The Repertoire of Heavy Chain Immunoglobulin Genes in B-Cell Chronic Lymphocytic Leukemia in Russia and Belarus

Bella Biderman, Eugene Nikitin, Tatiana Sergienko, Alexandra Bakun, Irina Taras, Arcadi Svirnovski, Andrey Sudarikov

Blood (2012) 120 (21): 4579.

https://doi.org/10.1182/blood.V120.21.4579.4579

Published: 2012

Journal Articles

Safety of Bendamustine Monotherapy in CLL Patients with Concomitant Chronic Renal Failure

Eugene Nikitin, Boldykyz Dzhumabaeva, Irina Kaplanskaya, Anait Melikyan, Ludmila Biryukova

Blood (2012) 120 (21): 4592.

https://doi.org/10.1182/blood.V120.21.4592.4592

Published: 2012

Journal Articles

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS)

Blood (2011) 118 (21): 263.

https://doi.org/10.1182/blood.V118.21.263.263

Published: 2011

Journal Articles

Early Response (ER) Is a Prognostic Marker for PFS in CLL Treated by Fludarabine Containing Regimens.

Elena Stadnik, Galina Salogub, Yulia Alekseeva, Natalija Lazorko, Eugene Nikitin, Andrey Zaritskey

Blood (2009) 114 (22): 2377.

https://doi.org/10.1182/blood.V114.22.2377.2377

Published: 2009

Journal Articles

CLL with enlarged Abdominal Lymph Nodes (EAL) Is An Entity with Decreased Response to Fludarabine Containing Regimens.

Elena Stadnik, Galina N. Salogub, Yulia Alekseeva, Natalija Lazorko, Eugene Nikitin, Andrey Zaritskey

Blood (2009) 114 (22): 4406.

https://doi.org/10.1182/blood.V114.22.4406.4406

Published: 2009

NARROW

Long-Term Prophylaxis with Activated Recombinant FVII in Children with Hemophilia a and Inhibitor, Receiving Treatment with ITI Protocol

Platelet Function Prior to Ibrutinib Treatment Is More Severely Impaired in Chronic Lymphocytic Leukemia Than in Mantle Cell Lymphoma

Safety and Efficiency of New Nonacog Alfa Drug in the Treatment of Bleeding Episodes in Patients with Severe and Moderate Hemophilia B

The Pharmacokinetic Properties, Safety and Tolerability of a New Nonacog Alfa (Innonafactor) in Patients with Hemophilia B

Safety and Efficacy of New Moroctocog Alfa Drug (Octofactor) in Prophylactic Treatment in Adolescent Patients with Severe and Moderate Hemophilia a

Safety and Efficacy of New Nonacog Alfa Drug (Innonafactor) in Prophylactic Treatment in Patients with Severe and Moderate Hemophilia B

Low Frequency Of IGHV4-39/IGHD6-13/IGHJ5 Rearrangement With Stereotyped HCDR3 (subset #8) In Russian and Ukrainian Chronic Lymphocytic Leukemia Patients

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

The Repertoire of Heavy Chain Immunoglobulin Genes in B-Cell Chronic Lymphocytic Leukemia in Russia and Belarus

Safety of Bendamustine Monotherapy in CLL Patients with Concomitant Chronic Renal Failure

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS)

Early Response (ER) Is a Prognostic Marker for PFS in CLL Treated by Fludarabine Containing Regimens.

CLL with enlarged Abdominal Lymph Nodes (EAL) Is An Entity with Decreased Response to Fludarabine Containing Regimens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only